APA

Campone M., Dobrovolskaya N., Tjulandin S., Chen S., Fourie S., Mefti F., Konstantinova M., Lefresne F., Meheust N. & Jassem J. (20131113). A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines. : The breast journal.

Chicago

Campone Mario, Dobrovolskaya Natalya, Tjulandin Serjei, Chen Shin-Chen, Fourie Sameul, Mefti Fawzia, Konstantinova Maria, Lefresne Florence, Meheust Nadege and Jassem Jacek. 20131113. A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines. : The breast journal.

Harvard

Campone M., Dobrovolskaya N., Tjulandin S., Chen S., Fourie S., Mefti F., Konstantinova M., Lefresne F., Meheust N. and Jassem J. (20131113). A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines. : The breast journal.

MLA

Campone Mario, Dobrovolskaya Natalya, Tjulandin Serjei, Chen Shin-Chen, Fourie Sameul, Mefti Fawzia, Konstantinova Maria, Lefresne Florence, Meheust Nadege and Jassem Jacek. A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines. : The breast journal. 20131113.